KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Idexx Laboratories (IDXX) FCF Margin (2016 - 2025)

Idexx Laboratories has reported FCF Margin over the past 17 years, most recently at 29.92% for Q4 2025.

  • Quarterly results put FCF Margin at 29.92% for Q4 2025, up 1405.0% from a year ago — trailing twelve months through Dec 2025 was 24.56% (up 383.0% YoY), and the annual figure for FY2025 was 24.56%, up 383.0%.
  • FCF Margin for Q4 2025 was 29.92% at Idexx Laboratories, down from 33.59% in the prior quarter.
  • Over the last five years, FCF Margin for IDXX hit a ceiling of 33.59% in Q3 2025 and a floor of 5.34% in Q4 2022.
  • Median FCF Margin over the past 5 years was 20.2% (2023), compared with a mean of 19.55%.
  • Biggest five-year swings in FCF Margin: plummeted -1780bps in 2022 and later surged 1876bps in 2023.
  • Idexx Laboratories' FCF Margin stood at 13.13% in 2021, then tumbled by -59bps to 5.34% in 2022, then surged by 351bps to 24.1% in 2023, then plummeted by -34bps to 15.88% in 2024, then soared by 88bps to 29.92% in 2025.
  • The last three reported values for FCF Margin were 29.92% (Q4 2025), 33.59% (Q3 2025), and 11.93% (Q2 2025) per Business Quant data.